Data from the Framingham Heart study, in which 85 biomarkers were evaluated, showed that GDF-15 was the only marker with a significant association with the three outcome results: atherosclerotic events, heart failure, and mortality [28]. This evidence concerns the gene GDF15 and heart failure.